Ophthalmic Solutions - Administration & dosage
Research News and Information

Sunday, November 22, 2009

A clinician's guide to the assessment and management of nonadherence in glaucoma.

30 Oct 2009 PURPOSE: To apply lessons learned in the treatment of systemic hypertension to the problem of nonadherence in glaucoma medical therapy. CLINICAL RELEVANCE: Although physicians recognize that nonadherence with glaucoma medication is a problem, most ... Read more...

Patient-centered communication to assess and enhance patient adherence to glaucoma medication.

30 Oct 2009 TOPIC: Using an understanding of a patient's difficulty in revealing nonadherence and patient-centered communication skills to identify and address barriers to adherence to glaucoma medication regimens. CLINICAL RELEVANCE: In addition to cost and ... Read more...

A comprehensive perspective on patient adherence to topical glaucoma therapy.

30 Oct 2009 TOPIC: Risk factors for poor adherence or nonadherence to topical glaucoma medication regimens. CLINICAL RELEVANCE: Poor adherence to glaucoma medication regimens may be associated with subsequent visual loss and irreversible optic nerve damage. ... Read more...

Latest indexed articles for 'Ophthalmic Solutions - Administration & dosage'

These are the very latest articles for this heading:

• A clinician's guide to the assessment and management of nonadherence in glaucoma. 30 Oct 2009
• Patient-centered communication to assess and enhance patient adherence to glaucoma medication. 30 Oct 2009
• A comprehensive perspective on patient adherence to topical glaucoma therapy. 30 Oct 2009
• Introduction: new insights on enhancing adherence to topical glaucoma medications. 30 Oct 2009
• Atropine treatment for myopia. 29 Sep 2009
• Conjunctival lichen planus in a patient with herpes simplex virus keratitis. 30 Aug 2009
• Proposed mandate for instructions and labeling regarding the use of eye drops. 30 Aug 2009
• Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata. 30 Aug 2009
• Aqueous humor penetration of fourth-generation fluoroquinolone ophthalmic solutions given by multiple administration in a rabbit model. 16 Aug 2009
• Betaxolol hydrochloride ophthalmic suspension 0.25% and timolol gel-forming solution 0.25% and 0.5% in pediatric glaucoma: a randomized clinical trial. 30 Jul 2009
• Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice. 30 Jul 2009
• Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans. 30 Jul 2009
• Efficacy of topical cyclosporine A in the treatment of severe trachomatous dry eye. 30 Jul 2009
• Pupil size with and without adrenaline with diclofenac use before cataract surgery. 30 Jul 2009
• Antibiotic therapy for trachoma. 30 Jul 2009
• Nepafenac: new drug. After cataract surgery: just another NSAID eye drop. No better than other NSAID eye drops, and less convenient to use. 30 Jul 2009
• Adult-onset exposure keratitis after childhood ptosis repair with frontalis sling procedure. 30 Jul 2009
• GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial. 27 Jul 2009
• Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis. 27 Jul 2009
• Evaluation of the cytotoxic effects of ophthalmic solutions containing benzalkonium chloride on corneal epithelium using an organotypic 3-D model. 26 Jul 2009

See a longer list of these articles.

Technical information about 'Ophthalmic Solutions'

Definition: Sterile solutions, essentially free from foreign particles and suitably compounded and dispensed, for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS. (From Dorland, 27th ed)

Registry Number: 0

Descriptor UI: D009883

Alternative terms: Ophthalmic Solutions; Solutions, Ophthalmic; Eyedrops; Eye Drops; Drops, Eye; Tears, Artificial; Artificial Tears;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; chemical synthesis; classification; diagnostic use; economics; history; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; chemistry; contraindications;

Tree Number: D26.255.775.645; D26.776.708.645; D27.720.280.775.645;

Online Note: use OPHTHALMIC SOLUTIONS to search SOLUTIONS, OPHTHALMIC 1966

History Note: 67; was SOLUTIONS, OPHTHALMIC 1963-66

Technical Notes: sterile solutions for instillation into the eyes: not for solutions for cleaning eyeglass lenses ( = SOLUTIONS + specific type of lens); not for cleaning contact lenses ( = CONTACT LENS SOLUTIONS); D25-26 qualif if IM & GEN; NIM coord with no qualif + specific drug IM; DF: OPHTHALMIC SOL